Effect of Xpcl1 activation and p27Kip1 loss on gene expression in murine lymphoma

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Kuppers, Daniel A ^a   Hwang, Harry C ^a,c   Jackson, Aimee L ^b,d   Linsley, Peter S ^b   Clurman, Bruce E ^a   Fero, Matthew L ^a  

^a USA   (United States)

^b ROSETTA INPHARMATICS   (United States)

^c PHENOPATH LABORATORIES   (United States)

^d REGULUS THERAPEUTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA; MYC PROTEIN; PROTEIN XPCL1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TUMOR PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCUS; GENE LOSS; GENE OVEREXPRESSION; GENE TARGETING; GENOTYPE; KNOCKOUT MOUSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NULL ALLELE; T CELL LYMPHOMA; TUMOR PROMOTION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA; METABOLISM; MOLONEY LEUKEMIA ONCOVIRUS; PHYSIOLOGY; THYMUS; VIRUS DNA CELL DNA INTERACTION;

MURINAE; MURINE LEUKEMIA VIRUS; MUS;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; LYMPHOMA; MICE; MICRORNAS; MOLONEY MURINE LEUKEMIA VIRUS; RNA, MESSENGER; THYMUS GLAND; VIRUS INTEGRATION;

EID: 79952583230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014758     Document Type: Article

References (44)

1. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ, (1998) The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396: 177-180.
2. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, et al. (2004) A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 101: 17204-17209.
3. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP, (2001) Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 27: 222-224.
4. Petrocelli T, Slingerland JM, (2001) PTEN deficiency: a role in mammary carcinogenesis. Breast Cancer Res 3: 356-360.
5. Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, et al. (2002) Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci U S A 99: 11293-11298.
6. Garrett-Engele CM, Tasch MA, Hwang HC, Fero ML, Perlmutter RM, et al. (2007) A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet 3: e219.
7. Landais S, Quantin R, Rassart E, (2005) Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene. J Virol 79: 11443-11456.
8. Lum AM, Wang BB, Li L, Channa N, Bartha G, Wabl M, (2007) Retroviral activation of the mir-106a microRNA cistron in T lymphoma. Retrovirology 4: 5.
9. Tanzer A, Stadler PF, (2004) Molecular evolution of a microRNA cluster. J Mol Biol 339: 327-335.
10. Landais S, Landry S, Legault P, Rassart E, (2007) Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67: 5699-5707.
11. Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, et al. (2008) Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133: 727-741.
12. Shivdasani RA, (2006) MicroRNAs: regulators of gene expression and cell differentiation. Blood.
13. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
14. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158.
15. Carthew RW, Sontheimer EJ, (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655.
16. Clurman BE, Hayward WS, (1989) Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol 9: 2657-2664.
17. Tam W, Ben-Yehuda D, Hayward WS, (1997) bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 17: 1490-1502.
18. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, et al. (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 103: 7024-7029.
19. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102: 3627-3632.
20. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, et al. (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207: 243-249.
21. Mu P, Han YC, Betel D, Yao E, Squatrito M, et al. (2009) Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23: 2806-2811.
22. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
23. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T, (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
24. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
25. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, et al. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21: 635-637.
26. Vasmel WL, Matthews EA, Gillis CP, Nieland J, Borst EA, et al. (1989) Distinct chromosomal abnormalities in murine leukemia virus-induced T- and B-cell lymphomas. Int J Cancer 43: 1112-1119.
27. Wang J, Nygaard V, Smith-Sorensen B, Hovig E, Myklebost O, (2002) MArray: analysing single, replicated or reversed microarray experiments. Bioinformatics 18: 1139-1140.
28. Guo Z, Dose M, Kovalovsky D, Chang R, O'Neil J, et al. (2007) Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood 109: 5463-5472.
29. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141.
30. Mellors RC, (1956) Quantitative cytology and cytopathology: nucleic acids and proteins in the mitotic cycle of normal and neoplastic cells. Ann N Y Acad Sci 63: 1177-1201.
31. Von Bertalanffy L, Masin M, Masin F, Kaplan L, (1957) Detection of gynecological cancer; use of fluorescence microscopy to show nucleic acids in malignant growth. Calif Med 87: 248-251.
32. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, et al. (2008) MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174.
33. Manni I, Artuso S, Careccia S, Rizzo MG, Baserga R, et al. (2009) The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms. FASEB J 23: 3957-3966.
34. Carrano AC, Eytan E, Hershko A, Pagano M, (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193-199.
35. Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, et al. (2010) Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma. Cancer Res 70: 3791-3802.
36. Raymond CK, Roberts BS, Garrett-Engele P, Lim LP, Johnson JM, (2005) Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 11: 1737-1744.
37. Tibshirani R, Hastie T, Narasimhan B, Chu G, (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99: 6567-6572.
38. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, et al. (2001) Missing value estimation methods for DNA microarrays. Bioinformatics 17: 520-525.
39. Breitling R, Armengaud P, Amtmann A, Herzyk P, (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92.
40. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
41. Iritani BM, Forbush KA, Farrar MA, Perlmutter RM, (1997) Control of B cell development by Ras-mediated activation of Raf. EMBO J 16: 7019-7031.
42. Megason SG, McMahon AP, (2002) A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development 129: 2087-2098.
43. Wu J, Bonsra AN, Du G, (2009) pSM155 and pSM30 vectors for miRNA and shRNA expression. Methods in Molecular Biology United States Springer Verlag pp. 205-219.
44. Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, et al. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014.